Loading organizations...
Loading organizations...
Developing dendritic cell vaccines for challenging cancer types.
Diakonos Oncology has raised $31.4M across 2 funding rounds.
Diakonos Oncology has raised $31.4M in total across 2 funding rounds.
Diakonos Oncology has raised $31.4M in total across 2 funding rounds.
Diakonos Oncology's investors include Mike Wicks, Joseph Petrosino, John Higgins, Buttonwood Group Advisors, Andrés Isaias.
Diakonos Oncology has raised $31.4M across 2 funding rounds. Most recently, it raised $20.0M Other Equity in June 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2025 | $20.0M Other Equity | Mike Wicks, Joseph Petrosino, John Higgins, Buttonwood Group Advisors | |
| Aug 26, 2024 | $11.4M Seed | Andrés Isaias |